Trials / Completed
CompletedNCT04473209
Serum Resistin Level Following Non-surgical Periodontal Therapy in Diabetic Patients With Chronic Periodontitis
The Effect of Non-surgical Periodontal Therapy on Serum Resistin Level in Chronic Periodontitis Patients With or Without Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 40 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
non-surgical periodontal debridement was performed for diabetic patients with chronic periodontitis as well as for non-diabetic patients but also with chronic periodontitis. Serum resistin level was assessed in the two groups before and after periodontal therapy and also was compared to a healthy control group.
Detailed description
Background: Resisitin is a recognized marker for chronic inflammatory conditions that could be directly linked with type 2 diabetes mellitus. The aim of this study was to assess serum resistin level in type 2 diabetic patients with chronic periodontitis. Methods: Forty individuals were recruited in this study and were divided into three groups, diabetic group consisted of 15 diabetic patients (type 2 diabetes mellitus) with moderate to severe chronic periodontitis, non-diabetic group consisted of 15 non-diabetic patients with moderate to severe chronic periodontitis and healthy group consisted of 10 non-diabetic individuals with healthy periodontium. Non-surgical periodontal therapy with supra and subgingival debridement was performed for the diabetic and non-diabetic groups. Pocket depth, clinical attachment level, plaque index, gingival index, serum Resistin and high sensitivity C-Reactive Protein assay were recorded for both groups before and after treatment, while HbA1c was recorded for the diabetic group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | non-surgical periodontal therapy | supra and subgingival debridement |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2019-09-30
- Completion
- 2020-01-30
- First posted
- 2020-07-16
- Last updated
- 2020-07-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04473209. Inclusion in this directory is not an endorsement.